Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital.
作者信息
Arcari Gabriele, Raponi Giammarco, Sacco Federica, Bibbolino Giulia, Di Lella Federica Maria, Alessandri Francesco, Coletti Monica, Trancassini Maria, Deales Alberto, Pugliese Francesco, Antonelli Guido, Carattoli Alessandra
机构信息
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy; Sapienza University Hospital 'Policlinico Umberto I', Rome, Italy.
出版信息
Int J Antimicrob Agents. 2021 Jan;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital.
Int J Antimicrob Agents. 2021 Jan;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245. Epub 2020 Nov 27.
2
Emergence of a Klebsiella pneumoniae ST392 clone harbouring KPC-3 in an Italian transplantation hospital.
J Hosp Infect. 2018 Mar;98(3):313-314. doi: 10.1016/j.jhin.2017.11.019. Epub 2017 Dec 5.
3
Increase in Prevalence of KPC-2-Producing Klebsiella pneumoniae Recovered From Respiratory Secretions of Intensive Care Patients-Getting a Free Ride on a Menacing Colistin Resistance.
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1521-1522. doi: 10.1017/ice.2016.231. Epub 2016 Oct 3.
4
Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball.
J Glob Antimicrob Resist. 2020 Dec;23:398-400. doi: 10.1016/j.jgar.2020.11.004. Epub 2020 Nov 23.
5
Cost of Nosocomial Outbreak Caused by NDM-1-Containing Klebsiella pneumoniae in the Netherlands, October 2015-January 2016.
Emerg Infect Dis. 2017 Sep;23(9):1574-1576. doi: 10.3201/eid2309.161710.
6
Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
Microb Drug Resist. 2016 Jul;22(5):392-8. doi: 10.1089/mdr.2015.0282. Epub 2016 Feb 3.
7
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
Int J Antimicrob Agents. 2012 Feb;39(2):178-80. doi: 10.1016/j.ijantimicag.2011.09.024. Epub 2011 Nov 21.
8
Efficient transmission of IncFIIY and IncL plasmids and Klebsiella pneumoniae ST101 clone producing OXA-48, NDM-1 or OXA-181 in Bucharest hospitals.
Int J Antimicrob Agents. 2016 Aug;48(2):223-4. doi: 10.1016/j.ijantimicag.2016.05.004. Epub 2016 Jun 23.
9
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.
New Microbiol. 2014 Jan;37(1):87-90. Epub 2014 Jan 15.
10
Environmental persistence of OXA-48-producing Klebsiella pneumoniae in a French intensive care unit.
Am J Infect Control. 2016 Mar 1;44(3):366-8. doi: 10.1016/j.ajic.2015.09.021. Epub 2015 Oct 30.
引用本文的文献
1
Prevalence of hypervirulent strains in COVID-19 patients with bacterial co-infections.
Front Microbiol. 2025 Feb 17;16:1535893. doi: 10.3389/fmicb.2025.1535893. eCollection 2025.
2
Screening of subsp. Strains with Multi-Drug Resistance and Virulence Profiles Isolated from an Italian Hospital between 2020 and 2023.
Antibiotics (Basel). 2024 Jun 15;13(6):561. doi: 10.3390/antibiotics13060561.
3
Country-wide expansion of a VIM-1 carbapenemase-producing Klebsiella oxytoca ST145 lineage in Poland, 2009-2019.
Eur J Clin Microbiol Infect Dis. 2023 Dec;42(12):1449-1457. doi: 10.1007/s10096-023-04682-x. Epub 2023 Oct 19.
4
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
Gut Microbes. 2023 Dec;15(2):2249146. doi: 10.1080/19490976.2023.2249146.
5
Carbapenem-Resistant in COVID-19 Era-Challenges and Solutions.
Antibiotics (Basel). 2023 Aug 4;12(8):1285. doi: 10.3390/antibiotics12081285.
6
A Comparative Study of Bacterial Infections Between COVID-19 and Non-COVID-19 Patients With Respect to Different Isolates and Their Antibiotic Sensitivity Pattern.
Cureus. 2023 Jun 13;15(6):e40387. doi: 10.7759/cureus.40387. eCollection 2023 Jun.
7
Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals.
Microbiol Spectr. 2023 Jun 15;11(3):e0297222. doi: 10.1128/spectrum.02972-22. Epub 2023 Apr 12.
8
Problems Associated with Co-Infection by Multidrug-Resistant in COVID-19 Patients: A Review.
Healthcare (Basel). 2022 Nov 30;10(12):2412. doi: 10.3390/healthcare10122412.
9
Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains.
World J Microbiol Biotechnol. 2022 Oct 3;38(12):230. doi: 10.1007/s11274-022-03405-2.
10
Impact of the COVID-19 Pandemic on the Prevalence of HAIs and the Use of Antibiotics in an Italian University Hospital.
Healthcare (Basel). 2022 Aug 23;10(9):1597. doi: 10.3390/healthcare10091597.
本文引用的文献
1
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period.
J Med Virol. 2021 Feb;93(2):886-891. doi: 10.1002/jmv.26332. Epub 2020 Aug 2.
2
COVID-19: don't neglect antimicrobial stewardship principles!
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
3
Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.
N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Diversity, Virulence, and Antimicrobial Resistance in Isolates From the Newly Emerging ST101 Lineage.
Front Microbiol. 2019 Apr 2;10:542. doi: 10.3389/fmicb.2019.00542. eCollection 2019.
Zotero 插件